CSIMarket
 

Aclaris Therapeutics Inc   (ACRS)
Other Ticker:  
 

Aclaris Therapeutics Inc 's Working Capital Per Sales

ACRS's Working Capital and Revenue growth



ACRS Working Capital Per Revenue (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Working Capital Change -53.24 % -59.56 % -54.66 % -4.28 % 15.48 %
Y / Y Revenue Change 126.62 % -51.19 % 22.32 % 73.98 % 416.52 %
Working Capital Per Revenue 3.77 6.81 5.82 6.96 7.28
Total Ranking # 1472 # 2939 # 3070 # 2236 # 1490
Seq. Working Capital Change 2.37 % -13.12 % -33.68 % -20.73 % -11.47 %
Seq. Revenue Change 89.29 % 396.63 % -26.07 % -67.39 % -59.23 %





Comment on ACRS's Working Capital Per Revenue in the fourth quarter 2023
Aclaris Therapeutics Inc 's Working Capital Per Revenue in the Q4 2023 sequentially fell to 3.77 below the company average.

Within Healthcare sector 23 other companies have achieved lower Working Capital Per Revenue during the Q4 2023. While Aclaris Therapeutics Inc Working Capital Per Revenue overall ranking has impoved so far in the Q4 2023 to 1472, from total ranking in the third quarter 2023 at 2939.
Working Capital Per Revenue Ranking
Within: No.
Industry # 7
Sector # 24
S&P 500 # 1472


Working Capital Per Revenue Statistics
High Average Low
137.02
20.33
3.76
(Mar 31 2020)   (Dec 31 2023)



Financial Statements
Aclaris Therapeutics Inc 's Working Capital $ 98 Millions Visit ACRS's Balance sheet
Aclaris Therapeutics Inc 's Revenues $ 18 Millions Visit ACRS's Income Statement
Where are ACRS's Sales coming from? Visit ACRS's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Dec 31 2023, within Healthcare Sector Working Capital Per Revenue
Dbv Technologies S a   9.52 
Delcath Systems Inc   9.30 
Caribou Biosciences Inc   7.85 
Recursion Pharmaceuticals Inc   7.73 
Ac Immune Sa  7.54 
Prothena Corporation Public Limited Company  6.78 
Lipella Pharmaceuticals Inc   6.67 
Vaxart Inc   6.61 
Foghorn Therapeutics Inc   6.54 
Werewolf Therapeutics Inc   6.41 
Arcus Biosciences Inc   6.35 
Inspiremd Inc   5.95 
Curis Inc   5.87 
Innovative Eyewear Inc   5.32 
Hookipa Pharma inc   5.24 
Mersana Therapeutics Inc   5.11 
Aadi Bioscience Inc   5.03 
Maxcyte inc   4.98 
Profound Medical Corp   4.94 
Soligenix inc   4.73 
Arcutis Biotherapeutics Inc   4.72 
Cara Therapeutics inc   4.69 
Biontech Se  4.57 
Zymeworks Inc   4.42 
Liquidia Corporation  4.41 
Meiragtx Holdings Plc  4.36 
Legend Biotech Corporation  4.24 
Marker Therapeutics inc   4.19 
Neurometrix Inc   4.13 
Editas Medicine Inc   3.94 
Date modified: 2024-02-27T17:35:43+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com